Aberrations in folate metabolic pathway and altered susceptibility to autism

Objective To investigate whether genetic polymorphisms are the underlying causes for aberrations in folate pathway that was reported in autistic children. Basic methods A total of 138 children diagnosed as autistic based on Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria and Autism Behavior Checklist scoring and 138 age and sex matched children who are nonautistic were tested for five genetic polymorphisms, that is, cytosolic serine hydroxyl methyl transferase (SHMT1 C1420T), methylene tetrahydrofolate reductase (MTHFR C677T and MTHFR A1298C), methionine synthase reductase (MTRR A66G), methionine synthase (MS A2756G) using PCR-restriction fragment length polymorphism methods. Fisher's exact test and logistic regression analysis were used for statistical analyses. Results MTHFR 677T-allele frequency was found to be higher in autistic children compared with nonautistic children (16.3 vs. 6.5%) with 2.79-fold increased risk for autism [95% confidence interval (CI): 1.58–4.93]. The frequencies of MTRR 66A allele (12.7 vs. 21.0%) and SHMT 1420T allele (27.9 vs. 45.3%) were lower in autistic group compared with nonautistic group with odds ratios 0.55 (95% CI: 0.35–0.86) and 0.44 (95% CI: 0.31–0.62), respectively, indicating reduced risk. MTHFR 1298C-allele frequency was similar in both the groups (53.3 vs. 53.6%) and hence individually not associated with any risk. However, this allele was found to act additively in the presence of MTHFR 677T allele as evidenced by 8.11-fold (95% CI: 2.84–22.92) risk associated with MTHFR 677CT+TT/1298AC+CC genotypes cumulatively. Conclusion MTHFR C677T is a risk factor, whereas MTRR A66G and SHMT C1420T polymorphisms reduce risk for autism. MTHFR A1298C acts additively in increasing the risk for autism.

[1]  P. Kidd.  Autism, an extreme challenge to integrative medicine. Part: 1: The knowledge base. , 2002, Alternative medicine review : a journal of clinical therapeutic.

[2]  S. Folstein,et al.  Etiology of autism: genetic influences. , 1991, Pediatrics.

[3]  J. Galanko,et al.  Association of MTHFR Gene Variants with Autism , 2004 .

[4]  E. Callaway,et al.  Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children. , 1982, Acta vitaminologica et enzymologica.

[5]  H. Blom,et al.  Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? , 2001, Molecular genetics and metabolism.

[6]  Katherine L. Herbig,et al.  Cytoplasmic Serine Hydroxymethyltransferase Mediates Competition between Folate-dependent Deoxyribonucleotide andS-Adenosylmethionine Biosyntheses* , 2002, The Journal of Biological Chemistry.

[7]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[8]  Zhoutao Chen,et al.  Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Rimland.  Controversies in the Treatment of Autistic Children: Vitamin and Drug Therapy , 1988, Journal of child neurology.

[10]  R. Finnell,et al.  Cerebral folate deficiency with developmental delay, autism, and response to folinic acid , 2005, Neurology.

[11]  A. Neugut,et al.  Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. , 2007, Carcinogenesis.

[12]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[13]  A. Aro,et al.  Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. , 2001, The Journal of nutrition.

[14]  G. Morgan,et al.  Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. , 2002, Blood.

[15]  J. Akinsanya.  The knowledge base. , 1981, Nursing times.

[16]  S. Naushad,et al.  Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians , 2008, Clinical chemistry and laboratory medicine.

[17]  David A Geier,et al.  A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[18]  A. Bailey,et al.  Autism as a strongly genetic disorder: evidence from a British twin study , 1995, Psychological Medicine.

[19]  G. Shaw,et al.  Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. , 2003, Molecular genetics and metabolism.

[20]  J. Mason,et al.  Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal , 2004, Molecular Psychiatry.

[21]  A. Evans,et al.  The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. , 2001, Atherosclerosis.

[22]  R. Rozen,et al.  A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. , 1999, Molecular genetics and metabolism.

[23]  T. Wilens,et al.  Decreased Transmethylation of Biogenic Amines After In Vivo Elevation of Brain S‐Adenosyl‐l‐Homocysteine , 1981, Journal of neurochemistry.

[24]  R. Matthews,et al.  Human methionine synthase reductase is a molecular chaperone for human methionine synthase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Naushad,et al.  Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population , 2004 .

[26]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[27]  S. Masetti,et al.  Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage , 2003, European Journal of Human Genetics.

[28]  J. Bressler,et al.  A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A , 2004, American journal of medical genetics. Part A.

[29]  Stepan Melnyk,et al.  Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  P. Chiang.  Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. , 1998, Pharmacology & therapeutics.

[31]  J. Clegg,et al.  Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. , 1998, American journal of human genetics.

[32]  I. Pogribny,et al.  Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* , 2000, The Journal of Biological Chemistry.

[33]  P. Stover,et al.  5-Formyltetrahydrofolate Regulates Homocysteine Remethylation in Human Neuroblastoma* , 1997, The Journal of Biological Chemistry.

[34]  A. Brice,et al.  Combined vitamin B6-magnesium treatment in autism spectrum disorder. , 2002, The Cochrane database of systematic reviews.